Cancer is a genetic disease in the sense that it is caused by acquired mutations. In molecular pathology, these changes are detected and evaluated. The goal of our research is to implement and improve diagnostic approaches in pathology that involve molecular techniques.
Molecular pathology helps in classifying tumors, assessing the patient’s prognosis, selecting the optimal treatment strategy, predicting treatment response, and monitoring tumor regress and relapse. In these respects, nucleic-based analyses have become an essential part of today’s diagnostic platform in pathology.
Our group focuses on research projects that aim at improving current diagnostic approaches in molecular pathology. Our main projects involve studies of human papilloma virus (HPV) infection, lymphomas, sarcomas and non-small cell lung cancer.